Keep pulling the thread on Nayan Patel.
Neteera's technology can accurately identify patient deterioration 5 days in advance of an adverse event 77% of the time.
Neteera's system integrates with existing hospital nurse call environments and can also send alerts via API, email, or text message.
The biggest challenge for Neteera's market success is clinician adoption and change management, not the technology itself.
Neteera's future product roadmap includes adding features like bioID and arrhythmia detection to its contactless monitoring platform.
Neteera's contactless patient monitoring technology is an FDA Class II cleared medical device.
Neteera's technology uses high-frequency radar to detect heart rate, respiratory rate, motion, and sleep data through bedding and clothing.
The Neteera monitoring device works by detecting micro-movements on a patient's skin and does not use cameras or require wearables.
Neteera is developing a version of its monitoring technology for the home health market.
The primary use case for Neteera's predictive technology is in long-term care and skilled nursing facilities.
Neteera's platform can send data to an Electronic Medical Record (EMR) system via an HL7 feed, but the company's strategy is to focus on targeted alerts rather than bulk data transfer.